Top Story

Kala announces positive results in phase 2 dry eye trial

April 1, 2015

Kala Pharmaceuticals Inc. announced top-line results in a phase 2 clinical trial of KPI-121 in patients with dry eye disease, the company announced in a press release.

According to the release, KPI-121, a novel nanoparticle formulation of loteprednol etabonate that uses Kala's mucus-penetrating particle technology, met its primary sign endpoint in demonstrating statistical superiority of conjunctival hyperemia reduction.

Perspectives on Glaucoma

Ocular surface disease common in patients using antiglaucoma eye drops

March 30, 2015
The number of eye drops and eye drops containing benzalkonium chloride may contribute to the prevalence of ocular surface disease in glaucoma patients, according to a…
thumbnail for video 4138769948001 Meeting News CoverageVideo

VIDEO: Ocular allergic disease therapeutic update

March 29, 2015
Jodi Luchs, MD, FACS, discusses the proper diagnosis in patients with ocular allergies at Hawaiian Eye 2015.
In the Journals

Retaine ophthalmic emulsion may improve dry eye signs, symptoms

March 26, 2015
Retaine ophthalmic emulsion may be an effective therapy to reduce signs and symptoms of dry eye, according to a study.The single-center, open-label study evaluated 42…
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
thumbnail for video 4084488131001

VIDEO: Hot topics in dry eye disease for the cataract and refractive surgeon

February 28, 2015
WAILEA, Hawaii – At Hawaiian Eye 2015, James P. McCulley, MD, FACS, FRCOphth, discusses background and hot topics of…
More »

Kala announces positive results in phase 2 dry eye trial

April 1, 2015
Kala Pharmaceuticals Inc. announced top-line results in a phase 2 clinical trial of KPI-121 in patients with dry eye disease, the company announced…
Perspectives on Glaucoma

Ocular surface disease common in patients using antiglaucoma eye drops

March 30, 2015
The number of eye drops and eye drops containing benzalkonium chloride may contribute to the prevalence of ocular surface disease in glaucoma…
thumbnail for video 4138769948001 Meeting News CoverageVideo

VIDEO: Ocular allergic disease therapeutic update

March 29, 2015
Jodi Luchs, MD, FACS, discusses the proper diagnosis in patients with ocular allergies at Hawaiian Eye 2015.
In the Journals

Retaine ophthalmic emulsion may improve dry eye signs, symptoms

March 26, 2015
Retaine ophthalmic emulsion may be an effective therapy to reduce signs and symptoms of dry eye, according to a study.The single-center, open-label…
The Young Ophthalmologist: Learn DMEK based on protocols from NIIOS

The Young Ophthalmologist: Learn DMEK based on protocols from NIIOS

March 26, 2015
With the exception of a few staunch holdouts, almost everyone now agrees: Compared with conventional Descemet’s stripping endothelial keratoplasty…
Breaking News

Santen obtains European Commission approval to market Ikervis

March 25, 2015
Santen Pharmaceutical received approval from the European Commission for a marketing authorization application for Ikervis, according to a press…
In the Journals

Povidone-iodine may have led to decrease in postoperative endophthalmitis over 20 years

March 17, 2015
Preoperative povidone-iodine treatment may be a contributing factor in the decrease of postoperative endophthalmitis over a 20-year period, according…
Meeting News Coverage

Cornea specialist outlines ideal candidate for cross-linking

March 12, 2015
ATLANTA – As corneal collagen cross-linking makes its way through the FDA approval process, a presenter here at SECO shared pearls for patient…
Meeting News Coverage

Higher incidence of Acanthamoeba keratitis persists more than 10 years after outbreak

March 12, 2015
PHILADELPHIA — The incidence of Acanthamoeba keratitis, although still rare, is about 10 times greater than before an outbreak of the disease…
Meeting News Coverage

New case released, product changes planned for Alcon's peroxide solution

March 10, 2015
ATLANTA – Alcon announced here at SECO that its ClearCare hydrogen peroxide solution will now come packaged with a new-and-improved lens case…
More Headlines »
morganatic-roan